Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;35(5-6):340-6.
doi: 10.1159/000343074. Epub 2013 Apr 18.

Aromatase variants modify risk for Alzheimer's disease in a multiethnic female cohort

S C Janicki  1 , N Park, R Cheng, N Schupf, L N Clark, J H Lee
Affiliations

Aromatase variants modify risk for Alzheimer's disease in a multiethnic female cohort

S C Janicki et al. Dement Geriatr Cogn Disord. 2013.

Abstract

Background/aims: Few studies of gene variants that affect estrogen activity investigate their association with risk for Alzheimer's disease (AD) in women of different ethnicities. We investigated the influence of CYP19 polymorphisms on risk for AD in a multiethnic cohort of women, with individual ethnicity assessed by genetic population ancestry informative markers (AIMs) as well as by self-identified ethnicity.

Methods: Among 1,686 women participating in the Washington Heights Inwood Columbia Aging Project, association with risk for AD was assessed for 41 single nucleotide polymorphisms (SNPs) on the CYP19 gene using multivariable logistic regression, adjusting for age, presence of an APOE ε4 allele, years of education, and body mass index.

Results: Risk for AD was associated with 6 SNPs in women of predominantly Caucasian AIMs-defined ancestry. Of these, 2 were also associated with decreased risk of AD in women of admixed/Hispanic AIMs ancestry. Two separate SNPs were found to be protective in women of predominantly African AIMs-based ancestry.

Conclusions: CYP19 polymorphisms affect risk for AD in women, and risk alleles vary by AIMs-defined ancestry. These effects are possibly due to linkage disequilibrium patterns or differences in the prevalence of comorbid risk factors mediating the SNP effect on risk for AD by group.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Plot of WHICAP participants by AIMs-defined ancestry versus HapMap populations
WHICAP participants Yellow: Predominantly Caucasian AIMs-defined ancestry Green: Admixed/Hispanic AIMs-defined ancestry Blue: Predominantly African AIMs-defined ancestry HapMap populations Light Brown: Ancestrally homogenous Caucasian population (CEPH) Light Blue: Ancestrally homogenous Yoruban Black population (YRI) Red: Ancestrally homogenous East Asian population (CHJA)
See this image and copyright information in PMC

References

    1. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol. 1997;388:507–525. DOI: 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6 [pii] - PubMed
    1. McEwen BS. Invited review: Estrogens effects on the brain: Multiple sites and molecular mechanisms. J Appl Physiol. 2001;91:2785–2801. - PubMed
    1. Stoffel-Wagner B, Watzka M, Schramm J, Bidlingmaier F, Klingmuller D. Expression of CYP19 (aromatase) mRNA in different areas of the human brain. J Steroid Biochem Mol Biol. 1999;70:237–241. - PubMed
    1. Huang R, Poduslo SE. CYP19 haplotypes increase risk for Alzheimer’s disease. J Med Genet. 2006;43:e42. DOI: 43/8/e42 [pii] 10.1136/jmg.2005.039461. - PMC - PubMed
    1. Iivonen S, Corder E, Lehtovirta M, Helisalmi S, Mannermaa A, Vepsalainen S, Hanninen T, Soininen H, Hiltunen M. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology. 2004;62:1170–1176. - PubMed

Publication types

Grants and funding